Administered By

• Psychiatry & Behavioral Sciences, Translational Neuroscience

Awarded By

• Rescindo Therapeutics Inc 

Contributors

• Wetsel, William Christopher Principal Investigator

Start/End

• October 1, 2019 - June 30, 2020